Smita Agarwal, MD
Dermatology · Bridgewater, NJNPI 1982675633
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,621 of the $15,143 with a category attached, or 76.7%. It is spread thinly across 43 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,693, 2.3 times the $2,023 reported in 2019.
Across 866 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$3K
- AbbVie$1K
- LEO Pharma Inc.$1K
- Sanofi$1K
- Sun Pharmaceutical Industries Inc.$1K
- Johnson & Johnson$1K
- plus $6K from 37 others
Across 6 payments — averaging $4243.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$25K
What the payments were for
- Consulting fees$2,60317%
- Speaking & faculty fees$3502%
- Food & beverage$11,62177%
- Education$5704%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$350
- BF-RhodoLED$350
- DUPIXENT$139
How this compares
$15,143 in reported general payments places this provider in the 85th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 50 | $5,359 |
| Clobetasol Propionate | 101 | $3,656 |
| Fluorouracil | 37 | $2,259 |
| Halobetasol Propionate | 43 | $1,581 |
| Ketoconazole | 77 | $1,204 |
| Imiquimod | 36 | $1,020 |
| Clindamycin Phosphate | 24 | $879 |
| Ciclopirox | 25 | $752 |
| Mupirocin | 71 | $718 |
| Metronidazole | 13 | $686 |
| Minoxidil | 34 | $335 |
| Triamcinolone Acetonide | 43 | $149 |
| Prednisone | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bridgewater
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
- Jason MillerFreehold$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.